ABVC BioPharma Files 8-K Amendment
Ticker: ABVC · Form: 8-K/A · Filed: Apr 16, 2025 · CIK: 1173313
| Field | Detail |
|---|---|
| Company | Abvc Biopharma, Inc. (ABVC) |
| Form Type | 8-K/A |
| Filed Date | Apr 16, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, financial-condition, disclosure
TL;DR
ABVC BioPharma filed an 8-K amendment on April 16, 2025, updating prior financial/operational disclosures from April 15, 2025.
AI Summary
ABVC BioPharma, Inc. filed an amendment (8-K/A) on April 16, 2025, to a previous Form 8-K. The amendment pertains to Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) of the original filing, which occurred on April 15, 2025. The specific details of the amendment are not elaborated in the provided text, but it relates to financial condition and results of operations.
Why It Matters
This amendment indicates that ABVC BioPharma is providing updated or corrected information related to its financial condition or operational results, which could be material for investors to consider.
Risk Assessment
Risk Level: low — The filing is an amendment to a previous report, suggesting a correction or update rather than a new, significant event.
Key Numbers
- 001-40700 — SEC File Number (Identifies the specific SEC filing for ABVC BioPharma, Inc.)
Key Players & Entities
- ABVC BIOPHARMA, INC. (company) — Registrant
- 0001173313 (company) — Central Index Key
- 260014658 (company) — IRS Employer Identification Number
- April 16, 2025 (date) — Filing Date
- April 15, 2025 (date) — Earliest Event Reported Date
FAQ
What specific information is being amended in the Form 8-K?
The provided text does not specify the exact details of the amendment, only that it is an amendment to a previous Form 8-K filed on April 15, 2025, and relates to Items 8.01 and 9.01.
What was the original filing date of the Form 8-K being amended?
The original Form 8-K was filed on April 15, 2025.
What is the filing date of this amendment (Form 8-K/A)?
This amendment (Form 8-K/A) was filed on April 16, 2025.
What are the relevant SEC filing items addressed by this amendment?
The amendment pertains to Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) of the original Form 8-K.
In which state was ABVC BioPharma, Inc. incorporated?
ABVC BioPharma, Inc. was incorporated in Nevada.
Filing Details
This Form 8-K/A (Form 8-K/A) was filed with the SEC on April 16, 2025 regarding ABVC BIOPHARMA, INC. (ABVC).